No dematerialisation requests received in H1 FY27

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹48.45

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+0.7% vs market

Specialty Chemicals peers, median of 101sector+0.2%+0.6% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 0.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9+0.2+0.7+0.2+0.6

Next day

+0.9+0.9+0.0+0.9-0.0

+1.5-0.8+2.3-0.0+1.6

+1.1-0.1+1.2+0.3+0.8

+6.8-1.7+8.5-1.0+7.8

+3.2-4.3+7.5-4.5+7.7

+5.3-7.5+12.7-7.9+13.2

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 101Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Eiko Lifesciences filed a Regulation 74(5) certificate with BSE for the half year ended 30 September 2026. Registrar Bigshare Services confirmed that no dematerialisation requests for equity shares were received between 1 June 2026 and 30 September 2026. This is a routine compliance submission.

Likely market impact

Routine compliance filing; no material impact on shareholders or stock price.